Suitable Method for Routine Diagnostics of EER in Children With Otitis Media With Effusion
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02183974 |
Recruitment Status :
Completed
First Posted : July 8, 2014
Last Update Posted : July 8, 2014
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Otitis Media With Effusion | Procedure: Peptest | Not Applicable |
Children at the age between 1 to 7 years diagnosed with bilateral or unilateral OME who underwent adenoidectomy and myringotomy with insertion of ventilation tube were included in the prospective study. OME was defined as effusion in the middle ear behind intact eardrum longer than 3 months. Diagnosis was made on the basis of otomicroscopic findings, pneumatic otoscopy, type B tympanometry and audiometry (in older cooperative children). Children with no fluid in middle ear during myringotomy were revised as having tympanosclerosis and were excluded from the study. Children with craniofacial abnormities (Down syndrome, Treacher Collins syndrome, clefts etc.) were excluded from the study, as well. Demographic data and symptoms of EER disease were provided by parents, who were particularly inquired regarding the hoarseness, recurrent lower respiratory infection (bronchitis, pneumonia) and bronchial asthma of their child.
Myringotomy using microscope was done in anterior inferior part of the tympanic membrane. Type of middle ear effusion (fluid, mucous) was registered. Middle ear fluid was collected by special suction device with collecting bottle and ventilation tube was inserted in the tympanic membrane. In case of bilateral OME, effusion was collected and analysed separately. Specimen was first standardized. An amount of 0.1 ml of 10 % citric acid was added, specimen was centrifuged for 10 minutes and subsequently original migration reagent was added. Afterwards, specimen was examined using Peptest, which contains monoclonal antibodies targeted against pepsin. Result of the Peptest was stated as positive (2 lines), negative (1 line) and invalid (no line). Peptest detection limit is 16ng/ml of pepsin. Statistical analysis was done using MS Excel.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 44 participants |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Diagnostic |
Official Title: | Suitable Method for Routine Diagnostics of EER in Children With Otitis Media With Effusion |
Study Start Date : | June 2012 |
Actual Primary Completion Date : | March 2014 |
Actual Study Completion Date : | May 2014 |

Arm | Intervention/treatment |
---|---|
Experimental: Peptest
44 children at the age between 1 to 7 years diagnosed with bilateral or unilateral OME who underwent adenoidectomy and myringotomy with insertion of ventilation tube. Effusion was collected and analysed using Peptest, which contains monoclonal antibodies targeted against pepsin. Result of the Peptest was stated as positive (2 lines), negative (1 line) and invalid (no line).
|
Procedure: Peptest |
- The frequency of the presence of pepsin in effusion in the middle ear as an indirect diagnostic method of extraesophageal reflux in children with otitis media with effusion [ Time Frame: 2 years ]The frequency of the presence of pepsin in effusion in the middle ear was detected using Peptest in children with OME

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 1 Year to 7 Years (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- signing of the informed consent
- children at the age between 1 to 7 years diagnosed with bilateral or unilateral OME
Exclusion Criteria:
- children with craniofacial abnormities (Down syndrome, Treacher Collins syndrome, clefts etc.)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02183974
Czech Republic | |
University Hospital Ostrava | |
Ostrava, Moravian-Silesian Region, Czech Republic, 708 52 |
Principal Investigator: | Martin Formánek, MD | University Hospital Ostrava |
Publications:
Responsible Party: | University Hospital Ostrava |
ClinicalTrials.gov Identifier: | NCT02183974 History of Changes |
Other Study ID Numbers: |
FNO-ENT-OME Restech |
First Posted: | July 8, 2014 Key Record Dates |
Last Update Posted: | July 8, 2014 |
Last Verified: | July 2014 |
otitis media with effusion Laryngopharyngeal Reflux |
Otitis Otitis Media Otitis Media with Effusion Ear Diseases Otorhinolaryngologic Diseases |